var data={"title":"Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Michelle Lai, MD, MPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 12, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hepatitis A infection is caused by the hepatitis A virus (HAV). Humans are the only known reservoir. HAV infection is usually a self-limited illness that does not become chronic. Fulminant hepatic failure occurs in less than 1 percent of cases. Infection confers lifelong immunity and is preventable via vaccination.</p><p>HAV is a member of the genus <em>Hepatovirus</em> in the family Picornaviridae. Two clinical forms of hepatitis were recognized in 1947 and designated hepatitis A and hepatitis B [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]; subsequently, the virus that causes hepatitis A was identified in 1973 [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. Other terms previously used for hepatitis A virus infection include epidemic jaundice, acute catarrhal jaundice, and campaign jaundice.</p><p>The epidemiology, clinical manifestations, diagnosis, and treatment of HAV infection in adults are reviewed here. Issues related to HAV vaccination are presented separately, as are issues related to HAV in children and pregnant women. (See <a href=\"topic.htm?path=hepatitis-a-virus-infection-treatment-and-prevention\" class=\"medical medical_review\">&quot;Hepatitis A virus infection: Treatment and prevention&quot;</a> and <a href=\"topic.htm?path=overview-of-hepatitis-a-virus-infection-in-children\" class=\"medical medical_review\">&quot;Overview of hepatitis A virus infection in children&quot;</a> and <a href=\"topic.htm?path=intercurrent-hepatobiliary-disease-during-pregnancy#H3\" class=\"medical medical_review\">&quot;Intercurrent hepatobiliary disease during pregnancy&quot;, section on 'Hepatitis A'</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hepatitis A virus (HAV) infection occurs worldwide. Globally, an estimated 1.4 million cases occur each year [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/3\" class=\"abstract_t\">3</a>]. Hepatitis A can occur sporadically or in an epidemic form [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>].</p><p>HAV is usually transmitted by the fecal-oral route (either via person-to-person contact or consumption of contaminated food or water). Risk factors for HAV transmission are summarized in the table (<a href=\"image.htm?imageKey=GAST%2F80824\" class=\"graphic graphic_table graphicRef80824 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/5-9\" class=\"abstract_t\">5-9</a>]. Maternal-fetal transmission has not been described.</p><p>The incidence of HAV has declined substantially since implementation of vaccination:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the United States, since vaccination was recommended for individuals at increased risk for infection (in 1996), for children living in states with the highest incidence of HAV (in 1999), and for all infants (in 2006), the incidence of acute hepatitis A has declined from 6 to 0.4 cases per 100,000 between 1999 and 2014; an estimated 2500 cases of hepatitis A occurred in 2014 (<a href=\"image.htm?imageKey=ID%2F60763\" class=\"graphic graphic_figure graphicRef60763 \">figure 1</a> and <a href=\"image.htm?imageKey=ID%2F109037\" class=\"graphic graphic_figure graphicRef109037 \">figure 2</a>) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/5,10-16\" class=\"abstract_t\">5,10-16</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In China, the incidence among individuals age &le;19 years in one province declined to a historically low rate in 2014, while the highest incidence rate was observed in those aged &ge;20 years [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>]. In addition, improvement of living conditions in developing countries has been associated with fewer child infections, leading to a larger population of adults who lack protective antibodies and are at risk for outbreaks (<a href=\"image.htm?imageKey=ID%2F69392\" class=\"graphic graphic_figure graphicRef69392 \">figure 3</a>) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>].</p><p/><p>Hepatitis outbreaks have occurred in a variety of settings, including community outbreaks due to contaminated water or food (cooked foods can transmit HAV if the cooking temperature is inadequate to kill the virus or if food is contaminated after cooking) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/14,18-23\" class=\"abstract_t\">14,18-23</a>], outbreaks in healthcare settings, and outbreaks among homeless individuals [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/24-26\" class=\"abstract_t\">24-26</a>]. In 2017, more than 650 individuals in California were infected with hepatitis A (including 417 hospitalizations and 21 deaths), making this the largest outbreak in the United States in two decades [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>].</p><p>International outbreaks have occurred via importation of contaminated food from areas where HAV is endemic [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/20,21,28\" class=\"abstract_t\">20,21,28</a>]. In some circumstances, seemingly sporadic occurrences may reflect cases from geographically distant outbreaks. In one report, for example, 213 cases of hepatitis A were detected from 23 schools in Michigan and 29 cases from 13 schools in Maine; all were related to contaminated frozen strawberries from a common source [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/29\" class=\"abstract_t\">29</a>].</p><p>Fulminant hepatic failure develops in less than 1 percent of patients with hepatitis A [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>]; it occurs most commonly among patients with underlying liver disease, particularly chronic hepatitis C virus infection [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/15,31,32\" class=\"abstract_t\">15,31,32</a>]. In one study including 163 patients with chronic hepatitis B and 432 patients with chronic hepatitis C followed prospectively, hepatitis A superinfection occurred in 27 patients [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>]. Among 17 patients with hepatitis C who acquired hepatitis A, fulminant hepatic failure developed in 7 cases, of whom 6 died. Among 10 patients with hepatitis B who acquired hepatitis A, 9 had uncomplicated infection; one patient developed marked cholestasis in the setting of preexisting cirrhosis.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hepatic injury occurs as a result of the host immune response to hepatitis A virus (HAV). Viral replication occurs in the hepatocyte cytoplasm; hepatocellular damage and destruction of infected hepatocytes is mediated by human leukocyte antigen&ndash;restricted, HAV-specific CD8+ T lymphocytes and natural killer cells [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/33-35\" class=\"abstract_t\">33-35</a>]. Interferon-gamma appears to have a central role in promoting clearance of infected hepatocytes [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>]. An excessive host response (denoted by a marked reduction of circulation HAV RNA during acute infection) is associated with severe hepatitis [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H3024115574\"><span class=\"h2\">Typical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute hepatitis A virus (HAV) infection in adults is usually a self-limited illness; fulminant hepatic failure occurs in less than 1 percent of cases. The incubation period of hepatitis A infection averages 28 days (range 15 to 50 days) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>].</p><p>More than 70 percent of adults with HAV have symptomatic illness, which begins with abrupt onset of nausea, vomiting, anorexia, fever, malaise, and abdominal pain (<a href=\"image.htm?imageKey=GAST%2F57931\" class=\"graphic graphic_figure graphicRef57931 \">figure 4</a>) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/38\" class=\"abstract_t\">38</a>]. Within a few days to a week, dark urine (bilirubinuria) appears; pale stools (lacking bilirubin pigment) may also be observed. These are followed by jaundice and pruritus (40 to 70 percent of cases). The early signs and symptoms usually diminish when jaundice appears, and jaundice typically peaks within two weeks.</p><p>Physical findings include fever, jaundice, scleral icterus, hepatomegaly (80 percent of cases), and abdominal pain [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/4,39\" class=\"abstract_t\">4,39</a>]. Less common findings include splenomegaly and extrahepatic manifestations such as skin rash and arthralgias. (See <a href=\"#H42342034\" class=\"local\">'Extrahepatic manifestations'</a> below.)</p><p>Laboratory abnormalities include elevations of serum aminotransferases (often &gt;1000 international <span class=\"nowrap\">units/dL),</span> serum bilirubin (typically &le;10 <span class=\"nowrap\">mg/dL),</span> and alkaline phosphatase (up to 400 <span class=\"nowrap\">U/L)</span> [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/39\" class=\"abstract_t\">39</a>]. The serum aminotransferase elevations precede the bilirubin elevation. Serum alanine aminotransferase (ALT) is commonly higher than the serum aspartate aminotransferase (AST). Serum aminotransferases peak approximately one month after exposure to the virus and then decline by approximately 75 percent per week [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. The serum bilirubin concentration usually declines within two weeks of peak levels [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. Other laboratory abnormalities include elevations of acute-phase reactants and inflammatory markers.</p><p>Infected individuals are contagious during the incubation period and remain so for about a week after jaundice appears [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/41\" class=\"abstract_t\">41</a>]. HAV replicates in the liver and is shed in the stool in high concentrations from two to three weeks before to one week after onset of clinical illness (<a href=\"image.htm?imageKey=GAST%2F57931\" class=\"graphic graphic_figure graphicRef57931 \">figure 4</a>) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/42\" class=\"abstract_t\">42</a>].</p><p>Full clinical and biochemical recovery is observed within two to three months in 85 percent of patients, and complete recovery is observed by six months in nearly all patients [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. HAV infection does not become chronic, and individuals cannot become reinfected after recovering from infection.</p><p>Fulminant hepatic failure refers to the development of severe acute liver injury with encephalopathy and impaired synthetic function (international normalized ratio [INR] &ge;1.5). It occurs most commonly in individuals &gt;50 years of age and individuals with other liver diseases such as hepatitis B or C [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/30\" class=\"abstract_t\">30</a>]. (See <a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H42342034\"><span class=\"h2\">Extrahepatic manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of extrahepatic manifestations associated with hepatitis A virus infection have been described. Extrahepatic manifestations occur most commonly in patients who have protracted illness such as relapsing or cholestatic hepatitis [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/43,44\" class=\"abstract_t\">43,44</a>]. (See <a href=\"#H2677603502\" class=\"local\">'Cholestatic hepatitis'</a> below and <a href=\"#H1914349308\" class=\"local\">'Relapsing hepatitis'</a> below.)</p><p>The most common extrahepatic manifestations include evanescent rash and arthralgias (occurring in 10 to 15 percent of patients). Other conditions related to immune complex disease and vasculitis also occur, including [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/43-48\" class=\"abstract_t\">43-48</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Leukocytoclastic vasculitis (most often apparent on the legs and buttocks; biopsy demonstrates anti-HAV immunoglobulin (Ig)M and complement in the blood vessel walls)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arthritis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glomerulonephritis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cryoglobulinemia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Optic neuritis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Transverse myelitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Toxic epidermal necrolysis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myocarditis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thrombocytopenia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aplastic anemia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Red cell aplasia</p><p/><p class=\"headingAnchor\" id=\"H2658326809\"><span class=\"h2\">Complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Complications of acute hepatitis A infection include cholestatic hepatitis, relapsing hepatitis, and autoimmune hepatitis [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>].</p><p class=\"headingAnchor\" id=\"H2677603502\"><span class=\"h3\">Cholestatic hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prolonged cholestasis is characterized by a protracted period of jaundice (lasting &gt;3 months); it occurs among fewer than 5 percent of patients with acute hepatitis A infection [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/49,50\" class=\"abstract_t\">49,50</a>].</p><p>The course of cholestatic hepatitis is usually characterized by marked jaundice, pruritus, fever, weight loss, diarrhea, and malaise [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/39,45,49,51\" class=\"abstract_t\">39,45,49,51</a>]. Laboratory findings include markedly elevated serum bilirubin (often &gt;10 <span class=\"nowrap\">mg/dL)</span> and alkaline phosphatase, modest elevation of serum aminotransferases, and elevated serum cholesterol. Peak bilirubin levels may be reached in the eighth week or later.</p><p>In general, cholestatic hepatitis resolves spontaneously with no sequelae; recognition is important to avoid unnecessary testing. Ultrasonography is appropriate to exclude biliary obstruction; cholangiography or liver biopsy are usually not necessary [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/49\" class=\"abstract_t\">49</a>].</p><p>Treatment is usually supportive; there is no role for corticosteroids [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/45,49\" class=\"abstract_t\">45,49</a>]. <a href=\"topic.htm?path=cholestyramine-resin-drug-information\" class=\"drug drug_general\">Cholestyramine</a> may be administered if pruritus is bothersome.</p><p class=\"headingAnchor\" id=\"H1914349308\"><span class=\"h3\">Relapsing hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Up to 10 percent of patients experience a relapse of symptoms during the six months after acute illness [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/42,45,52-56\" class=\"abstract_t\">42,45,52-56</a>]. The duration of clinical relapse is generally less than 3 weeks, although biochemical relapse may last as long as 12 months [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. The cause of relapsing hepatitis is unknown, and no predisposing factors for relapse have been identified [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/52\" class=\"abstract_t\">52</a>].</p><p>The clinical course usually consists of apparent clinical recovery after acute infection with near normalization of the serum aminotransferases, followed by biochemical (and, in some cases, clinical) relapse; clinical manifestations of relapse are often milder than the initial episode [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/52\" class=\"abstract_t\">52</a>]. Serum aminotransferases may exceed 1000 international <span class=\"nowrap\">units/dL,</span> and serum anti-hepatitis A virus IgM antibodies typically persist throughout the course of the disease [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/52,57\" class=\"abstract_t\">52,57</a>]. HAV can be recovered from stool during relapse episodes, so such patients should be considered infectious [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. (See <a href=\"#H8\" class=\"local\">'Diagnosis'</a> below.)</p><p>Multiple relapses can occur. In one series including 297 adults with acute hepatitis A infection, relapse was observed in 13 percent of patients (of whom 22 percent had more than one relapse); approximately half of patients were asymptomatic during the relapses [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/53\" class=\"abstract_t\">53</a>]. Development of extrahepatic manifestations (such as arthritis, vasculitis, nephritis, and cryoglobulinemia) during relapse has been described [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/43,46\" class=\"abstract_t\">43,46</a>]. (See <a href=\"#H42342034\" class=\"local\">'Extrahepatic manifestations'</a> above.)</p><p>In general, patients with relapsing hepatitis have complete recovery; recognition is important to avoid unnecessary testing. Ultrasonography is appropriate to exclude biliary obstruction in patients with significant jaundice; cholangiography or liver biopsy are usually not necessary.</p><p class=\"headingAnchor\" id=\"H3399532467\"><span class=\"h3\">Autoimmune hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rarely, HAV infection may serve as a trigger for development of autoimmune hepatitis in susceptible individuals [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/58,59\" class=\"abstract_t\">58,59</a>]. Autoimmune hepatitis is a chronic hepatitis characterized by hyperglobulinemia, the presence of circulating autoantibodies (such as anti-nuclear, anti-smooth muscle, <span class=\"nowrap\">and/or</span> anti-actin antibodies), and inflammatory changes on liver histology.</p><p>Issues related to autoimmune hepatitis are discussed separately. (See <a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of acute hepatitis A virus (HAV) infection should be suspected in patients with abrupt onset of prodromal symptoms (nausea, anorexia, fever, malaise, or abdominal pain) and jaundice or elevated serum aminotransferase levels, particularly in the setting of known risk factors for hepatitis A transmission (<a href=\"image.htm?imageKey=GAST%2F80824\" class=\"graphic graphic_table graphicRef80824 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/14\" class=\"abstract_t\">14</a>].</p><p>The diagnosis is established by detection of serum immunoglobulin (Ig)M anti-HAV antibodies. Serum IgM antibodies are detectable at the time of symptom onset, peak during the acute or early convalescent phase of the disease, and remain detectable for approximately three to six months (<a href=\"image.htm?imageKey=GAST%2F57931\" class=\"graphic graphic_figure graphicRef57931 \">figure 4</a>). Among patients with relapsing hepatitis, serum IgM antibodies persist for the duration of this pattern of disease. (See <a href=\"#H1914349308\" class=\"local\">'Relapsing hepatitis'</a> above.)</p><p>Detection of serum IgM antibodies in the absence of clinical symptoms may reflect prior hepatitis A infection with prolonged persistence of IgM, a false-positive result, or asymptomatic infection (which is more common in children &lt;6 years of age than older children or adults) [<a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/60\" class=\"abstract_t\">60</a>].</p><p>Serum IgG antibodies appear early in the convalescent phase of the disease, remain detectable for decades, and are associated with lifelong protective immunity (<a href=\"image.htm?imageKey=GAST%2F57931\" class=\"graphic graphic_figure graphicRef57931 \">figure 4</a>). Detection of anti-HAV IgG in the absence of anti-HAV IgM reflects past infection or vaccination rather than acute infection.</p><p>Imaging studies are generally not needed for diagnosis of HAV infection. Ultrasonography is appropriate to alternate diagnoses (such as biliary obstruction); cholangiography or liver biopsy are usually not necessary.</p><p class=\"headingAnchor\" id=\"H5389616\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of hepatitis A virus infection includes other viruses that can cause hepatitis, all of which may be distinguished via serology:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatitis B, C, D, and E &ndash; Hepatitis A and E are acute infections transmitted by the fecal-oral route, whereas hepatitis B, C, and D can present acutely or chronically and are transmitted by body fluids. (See related topics.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Epstein-Barr and cytomegalovirus &ndash; Both Epstein-Barr and cytomegalovirus may present with liver function abnormalities as well as fever, fatigue, and lymphadenopathy. (See <a href=\"topic.htm?path=infectious-mononucleosis-in-adults-and-adolescents\" class=\"medical medical_review\">&quot;Infectious mononucleosis in adults and adolescents&quot;</a> and <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-treatment-of-cytomegalovirus-infection-in-immunocompetent-adults\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Yellow fever virus &ndash; Yellow fever virus is transmitted by mosquitoes in endemic regions; initial manifestations consist of malaise and other nonspecific symptoms, followed by acute illness with fever and gastrointestinal manifestations. (See <a href=\"topic.htm?path=yellow-fever\" class=\"medical medical_review\">&quot;Yellow fever&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpes simplex virus &ndash; Hepatitis is a rare complication of herpes simplex virus infection. It may present fulminantly, most commonly in immunocompromised hosts. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection#H22\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;, section on 'Hepatitis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adenovirus &ndash; Adenovirus infection typically involves the respiratory and gastrointestinal tracts; hepatitis may be a complication of adenovirus infection in immunocompromised hosts. (See <a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-adenovirus-infection#H16\" class=\"medical medical_review\">&quot;Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection&quot;, section on 'Gastrointestinal tract'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HIV infection &ndash; Patients with acute HIV infection may have nausea, diarrhea, and anorexia. More serious gastrointestinal manifestations such as hepatitis can occur though are rare. (See <a href=\"topic.htm?path=acute-and-early-hiv-infection-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute and early HIV infection: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p>Other infectious causes of fever and jaundice include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malaria &ndash; Malaria is a mosquito-borne parasitic infection characterized by fever, anemia, and parasitemia; clinical manifestations include jaundice due to hemolysis. The diagnosis may be established by examination of the peripheral blood smear. (See <a href=\"topic.htm?path=clinical-manifestations-of-malaria-in-nonpregnant-adults-and-children\" class=\"medical medical_review\">&quot;Clinical manifestations of malaria in nonpregnant adults and children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Leptospirosis &ndash; Leptospirosis is a bacterial infection characterized by fever, myalgia, headache, and conjunctival suffusion. Modest elevation of hepatic transaminases may be observed. The diagnosis is established by serology. (See <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leptospirosis\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leptospirosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Syphilis &ndash; Syphilis is sexually transmitted infection; secondary syphilis consists of a number of clinical manifestations including elevated serum alkaline phosphatase, often with normal or only slightly abnormal transaminases. The diagnosis is established by serology. (See <a href=\"topic.htm?path=syphilis-epidemiology-pathophysiology-and-clinical-manifestations-in-hiv-uninfected-patients#H8\" class=\"medical medical_review\">&quot;Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients&quot;, section on 'Clinical manifestations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Q fever &ndash; Q fever occurs as a result of infection with <em>Coxiella burnetii</em>; hepatic involvement includes transaminitis, hepatomegaly without jaundice, and granulomas on liver biopsy. The diagnosis is established by serology. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-q-fever\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Q fever&quot;</a>.)</p><p/><p>Noninfectious entities with presentations similar to hepatitis A infection include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drug-induced liver injury (DILI) &ndash; Liver injury can be associated with many drugs (<a href=\"image.htm?imageKey=GAST%2F70335\" class=\"graphic graphic_table graphicRef70335 \">table 2</a>). Patients with DILI may be asymptomatic with abnormal liver function tests or have malaise, anorexia, nausea, vomiting, right upper quadrant pain, dark urine, acholic stools, jaundice, and pruritus. The diagnosis may be established via liver biopsy. (See <a href=\"topic.htm?path=drug-induced-liver-injury\" class=\"medical medical_review\">&quot;Drug-induced liver injury&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Budd-Chiari syndrome &ndash; Budd-Chiari syndrome is defined as hepatic venous outflow tract obstruction. Patients with Budd-Chiari syndrome may present with acute or subacute liver disease or acute liver failure. The diagnosis is established via ultrasonography. (See <a href=\"topic.htm?path=budd-chiari-syndrome-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune hepatitis &ndash; Autoimmune hepatitis may be asymptomatic or present with nonspecific symptoms, such as malaise, anorexia, nausea, abdominal pain, itching, and arthralgia. The diagnosis is established via serologic testing and histology. (See <a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Autoimmune hepatitis: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Wilson disease &ndash; Wilson disease is a genetic disorder characterized by excess copper; it can present as acute hepatitis, jaundice, abdominal pain, and elevated transaminase levels (typically &lt;2000 international <span class=\"nowrap\">units/dL</span> with an aspartate <span class=\"nowrap\">aminotransferase/alanine</span> aminotransferase ratio &gt;2). The diagnosis is based on serum ceruloplasmin and copper levels and ocular slit-lamp examination for Kayser-Fleisher rings. (See <a href=\"topic.htm?path=wilson-disease-clinical-manifestations-diagnosis-and-natural-history\" class=\"medical medical_review\">&quot;Wilson disease: Clinical manifestations, diagnosis, and natural history&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=hepatitis-a-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Hepatitis A (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=hepatitis-a-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Hepatitis A (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H7717987\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatitis A infection is caused by the hepatitis A virus (HAV) that occurs worldwide. Hepatitis A is usually a self-limited illness that does not become chronic. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HAV is typically transmitted by the fecal-oral route (either via person-to-person contact or consumption of contaminated food or water). Risk factors for HAV transmission include residence in or travel to areas to poor sanitation, household or sexual contact with another person with hepatitis A, homosexual activity in men, exposure to daycare centers, exposure to residential institutions, and illicit drug use (<a href=\"image.htm?imageKey=GAST%2F80824\" class=\"graphic graphic_table graphicRef80824 \">table 1</a>). (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incubation period of HAV averages 28 days (range 15 to 50 days). Most adults with HAV infection have symptomatic illness which begins with abrupt onset of nausea, anorexia, fever, malaise, and abdominal pain. Within a few days to a week, dark urine and acholic stools appear, followed by jaundice and pruritus. The early clinical manifestations usually diminish when jaundice appears, and jaundice typically peaks within two weeks. (See <a href=\"#H6\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Laboratory abnormalities include elevations of serum aminotransferases (often &gt;1000 international <span class=\"nowrap\">units/dL),</span> followed by elevations of serum bilirubin (up to 10 <span class=\"nowrap\">mg/dL)</span>. Serum aminotransferases peak approximately one month after exposure to the virus and then decline by approximately 75 percent per week. The serum bilirubin concentration usually declines within two weeks of peak levels. (See <a href=\"#H6\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of acute HAV infection should be suspected in patients with abrupt onset of gastrointestinal signs and symptoms and jaundice or elevated serum aminotransferase levels, particularly in the setting of known risk factors for hepatitis A transmission (<a href=\"image.htm?imageKey=GAST%2F80824\" class=\"graphic graphic_table graphicRef80824 \">table 1</a>). The diagnosis is established by detection of serum immunoglobulin (Ig)M anti-HAV antibodies. (See <a href=\"#H8\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extrahepatic manifestations include evanescent rash, arthralgias, and other conditions related to immune complex disease and vasculitis. Complications of acute hepatitis A infection include cholestatic hepatitis, relapsing hepatitis, and autoimmune hepatitis. (See <a href=\"#H42342034\" class=\"local\">'Extrahepatic manifestations'</a> above and <a href=\"#H2658326809\" class=\"local\">'Complications'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fulminant hepatic failure occurs in less than 1 percent of patients with HAV infection. It consists of severe acute liver injury with encephalopathy and impaired synthetic function and occurs most commonly in individuals &gt;50 years of age and individuals with other liver diseases such as hepatitis B or C. Patients with fulminant hepatic failure should be transferred to a center capable of performing liver transplantation. (See <a href=\"#H6\" class=\"local\">'Clinical manifestations'</a> above and <a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H176781247\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Dr. Catherine Cheney, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">MacCallum FO. Homologous serum jaundice. Lancet 1947; 2:691.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973; 182:1026.</a></li><li class=\"breakAll\">World Health Organization. Global Alert and Response (GAR): Hepatitis A. http://www.who.int/csr/disease/hepatitis/whocdscsredc2007/en/index4.html#estimated (Accessed on July 13, 2016).</li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev 2001; 14:38.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Daniels D, Grytdal S, Wasley A, Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009; 58:1.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Klevens RM, Miller JT, Iqbal K, et al. The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch Intern Med 2010; 170:1811.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Bohm SR, Berger KW, Hackert PB, et al. Hepatitis A outbreak among adults with developmental disabilities in group homes--Michigan, 2013. MMWR Morb Mortal Wkly Rep 2015; 64:148.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Latash J, Dorsinville M, Del Rosso P, et al. Notes from the Field: Increase in Reported Hepatitis A Infections Among Men Who Have Sex with Men - New York City, January-August 2017. MMWR Morb Mortal Wkly Rep 2017; 66:999.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Bower WA, Nainan OV, Han X, Margolis HS. Duration of viremia in hepatitis A virus infection. J Infect Dis 2000; 182:12.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005; 294:194.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Mutsch M, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis 2006; 42:490.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Ly KN, Klevens RM. Trends in disease and complications of hepatitis A virus infection in the United States, 1999-2011: a new concern for adults. J Infect Dis 2015; 212:176.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention. Hepatitis A Questions and Answers for Health Professionals. http://www.cdc.gov/hepatitis/hav/havfaq.htm#general (Accessed on July 13, 2016).</li><li class=\"breakAll\">Centers for Disease Control and Prevention. Viral Hepatitis Surveillance: United States, 2013. US Department of Health and Human Services, Atlanta, GA 2016. https://www.cdc.gov/hepatitis/statistics/2014surveillance/pdfs/2014HepSurveillanceRpt_Rev2016-09-26.pdf (Accessed on September 11, 2017).</li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Murphy TV, Denniston MM, Hill HA, et al. Progress Toward Eliminating Hepatitis A Disease in the United States. MMWR Suppl 2016; 65:29.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Wang Z, Chen Y, Xie S, Lv H. Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults. PLoS One 2016; 11:e0153804.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">De Serres G, Cromeans TL, Levesque B, et al. Molecular confirmation of hepatitis A virus from well water: epidemiology and public health implications. J Infect Dis 1999; 179:37.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Dentinger CM, Bower WA, Nainan OV, et al. An outbreak of hepatitis A associated with green onions. J Infect Dis 2001; 183:1273.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005; 353:890.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Donnan EJ, Fielding JE, Gregory JE, et al. A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis 2012; 54:775.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Tang YW, Wang JX, Xu ZY, et al. A serologically confirmed, case-control study, of a large outbreak of hepatitis A in China, associated with consumption of clams. Epidemiol Infect 1991; 107:651.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Halliday ML, Kang LY, Zhou TK, et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis 1991; 164:852.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Chodick G, Ashkenazi S, Lerman Y. The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies. J Hosp Infect 2006; 62:414.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Wiseman R, Weil LM, Lozano C, et al. Notes from the Field: Health Care-Associated Hepatitis A Outbreak - Texas, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:425.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Kushel M. Hepatitis A Outbreak in California - Addressing the Root Cause. N Engl J Med 2018; 378:211.</a></li><li class=\"breakAll\">https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Immunization/Hepatitis-A-Outbreak.aspx (Accessed on December 07, 2017).</li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010; 28:6653.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Hutin YJ, Pool V, Cramer EH, et al. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med 1999; 340:595.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am 2000; 14:605.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 2006; 44:1589.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Vallbracht A, Fleischer B, Busch FW. Hepatitis A: hepatotropism and influence on myelopoiesis. Intervirology 1993; 35:133.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Fleischer B, Fleischer S, Maier K, et al. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 1990; 69:14.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Baba M, Hasegawa H, Nakayabu M, et al. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. J Clin Lab Immunol 1993; 40:47.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Rezende G, Roque-Afonso AM, Samuel D, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003; 38:613.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med 1985; 313:1059.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985; 122:226.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171 Suppl 1:S15.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992; 10 Suppl 1:S15.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Richardson M, Elliman D, Maguire H, et al. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001; 20:380.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Inman RD, Hodge M, Johnston ME, et al. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med 1986; 105:700.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Dan M, Yaniv R. Cholestatic hepatitis, cutaneous vasculitis, and vascular deposits of immunoglobulin M and complement associated with hepatitis A virus infection. Am J Med 1990; 89:103.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992; 10 Suppl 1:S18.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Ilan Y, Hillman M, Oren R, et al. Vasculitis and cryoglobulinemia associated with persisting cholestatic hepatitis A virus infection. Am J Gastroenterol 1990; 85:586.</a></li><li class=\"breakAll\">Lavine J, Bull F, Millward-Sadler G. Acute viral hepatitis. In: Wright's Liver and Biliary Disease, Millard-Sadler G, Wright R, Arthur M (Eds), WB Saunders, London 1992. p.681.</li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Shenoy R, Nair S, Kamath N. Thrombocytopenia in hepatitis A--an atypical presentation. J Trop Pediatr 2004; 50:241.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Gordon SC, Reddy KR, Schiff L, Schiff ER. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann Intern Med 1984; 101:635.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Jung YM, Park SJ, Kim JS, et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol 2010; 82:1318.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Schiraldi O, Modugno A, Miglietta A, Fera G. Prolonged viral hepatitis type A with cholestasis: case report. Ital J Gastroenterol 1991; 23:364.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Glikson M, Galun E, Oren R, et al. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore) 1992; 71:14.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Kassas AL, Telegdy L, M&eacute;hesfalvi E, et al. Polyphasic and protracted patterns of hepatitis A infection: a retrospective study. Acta Med Hung 1994; 50:93.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Bornstein JD, Byrd DE, Trotter JF. Relapsing hepatitis A: a case report and review of the literature. J Clin Gastroenterol 1999; 28:355.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Gr&uuml;nhage F, Spengler U, Fischer HP, Sauerbruch T. Autoimmune hepatitis--sequel of a relapsing hepatitis A in a 75-year-old woman. Digestion 2004; 70:187.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Sjogren MH, Tanno H, Fay O, et al. Hepatitis A virus in stool during clinical relapse. Ann Intern Med 1987; 106:221.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Rachima CM, Cohen E, Garty M. Acute hepatitis A: combination of the relapsing and the cholestatic forms, two rare variants. Am J Med Sci 2000; 319:417.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Vento S, Garofano T, Di Perri G, et al. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991; 337:1183.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Skoog SM, Rivard RE, Batts KP, Smith CI. Autoimmune hepatitis preceded by acute hepatitis A infection. Am J Gastroenterol 2002; 97:1568.</a></li><li><a href=\"https://www.uptodate.com/contents/hepatitis-a-virus-infection-in-adults-epidemiology-clinical-manifestations-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR Morb Mortal Wkly Rep 2005; 54:453.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2692 Version 28.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H7717987\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">PATHOGENESIS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H3024115574\" id=\"outline-link-H3024115574\">Typical manifestations</a></li><li><a href=\"#H42342034\" id=\"outline-link-H42342034\">Extrahepatic manifestations</a></li><li><a href=\"#H2658326809\" id=\"outline-link-H2658326809\">Complications</a><ul><li><a href=\"#H2677603502\" id=\"outline-link-H2677603502\">- Cholestatic hepatitis</a></li><li><a href=\"#H1914349308\" id=\"outline-link-H1914349308\">- Relapsing hepatitis</a></li><li><a href=\"#H3399532467\" id=\"outline-link-H3399532467\">- Autoimmune hepatitis</a></li></ul></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">DIAGNOSIS</a></li><li><a href=\"#H5389616\" id=\"outline-link-H5389616\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H15\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H7717987\" id=\"outline-link-H7717987\">SUMMARY</a></li><li><a href=\"#H176781247\" id=\"outline-link-H176781247\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/2692|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/60763\" class=\"graphic graphic_figure\">- Decline HAV incidence</a></li><li><a href=\"image.htm?imageKey=ID/109037\" class=\"graphic graphic_figure\">- Incidence of hepatitis A</a></li><li><a href=\"image.htm?imageKey=ID/69392\" class=\"graphic graphic_figure\">- Geography hepatitis A</a></li><li><a href=\"image.htm?imageKey=GAST/57931\" class=\"graphic graphic_figure\">- Clinical course HAV infection</a></li></ul></li><li><div id=\"ID/2692|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/80824\" class=\"graphic graphic_table\">- Modes transmission hepatitis A</a></li><li><a href=\"image.htm?imageKey=GAST/70335\" class=\"graphic graphic_table\">- Types of DILI</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-and-early-hiv-infection-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute and early HIV infection: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-liver-failure-in-adults-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-hepatitis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Autoimmune hepatitis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=budd-chiari-syndrome-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-q-fever\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Q fever</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-malaria-in-nonpregnant-adults-and-children\" class=\"medical medical_review\">Clinical manifestations of malaria in nonpregnant adults and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-induced-liver-injury\" class=\"medical medical_review\">Drug-induced liver injury</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-treatment-of-cytomegalovirus-infection-in-immunocompetent-adults\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leptospirosis\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of leptospirosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-a-virus-infection-treatment-and-prevention\" class=\"medical medical_review\">Hepatitis A virus infection: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infectious-mononucleosis-in-adults-and-adolescents\" class=\"medical medical_review\">Infectious mononucleosis in adults and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intercurrent-hepatobiliary-disease-during-pregnancy\" class=\"medical medical_review\">Intercurrent hepatobiliary disease during pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-hepatitis-a-virus-infection-in-children\" class=\"medical medical_review\">Overview of hepatitis A virus infection in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-adenovirus-infection\" class=\"medical medical_review\">Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-a-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Hepatitis A (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-a-the-basics\" class=\"medical medical_basics\">Patient education: Hepatitis A (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=syphilis-epidemiology-pathophysiology-and-clinical-manifestations-in-hiv-uninfected-patients\" class=\"medical medical_review\">Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=wilson-disease-clinical-manifestations-diagnosis-and-natural-history\" class=\"medical medical_review\">Wilson disease: Clinical manifestations, diagnosis, and natural history</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=yellow-fever\" class=\"medical medical_review\">Yellow fever</a></li></ul></div></div>","javascript":null}